Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,841 public trials 2,101 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC

NCT03380130

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Hospital Universitario de Cruces Barakaldo, Spain

Hospital Clinic Barcelona, Spain

Hospital Universitario 12 de Octubre Madrid, Spain

Hospital Universitario Gregorio Marañon Madrid, Spain

View Trial Details

Completed

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

NCT01295086

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations: Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Completed

Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas

NCT01556009

Conditions: Abnormalities, Multiple, Basal Cell Nevus Syndrome, Bone Cysts, +19 more
Locations: Children's Hospital Oakland Research Institiute Oakland, California, United States

Children's Hospital Research Center Oakland Oakland, California, United States

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)

NCT03086564

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations: The Angeles Clinic and Research Center Los Angeles, California, United States

Hackensack Medical Center Hackensack, New Jersey, United States

Carolina BioOncology Institute Huntersville, North Carolina, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

NCT00489086

Conditions: Abnormalities, Multiple, Basal Cell Nevus Syndrome, Bone Cysts, +19 more
Locations: Children's Hospital and Research Center Oakland Oakland, California, United States

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

NCT02113800

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
Locations: Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum Berlin, Germany

View Trial Details

Completed

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

NCT01297244

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Southern Cancer Center Mobile, Alabama, United States

Providence Health and Services Burbank, California, United States

David Geffen School of Medicine at UCLA Los Angeles, California, United States

Rocky Mountain Cancer Center Denver, Colorado, United States

View all 25 locations

View Trial Details

Completed

Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma

NCT01386632

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Sanford Roger Maris Cancer Center Fargo, North Dakota, United States

Sanford Hematology and Oncology Sioux Falls, South Dakota, United States

View Trial Details

Completed

Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas

NCT04122911

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Istituto Tumori di Napoli - Fondazione G. Pascale Naples, Campania, Italy

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions